Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Rational development of synergistic combinations of chemotherapy and molecular targeted agents for colorectal cancer treatment

Fig. 4

Functional analysis of the effect of BKM120 and/or MEK162 at the indicate doses in HCT116 cells. (a) FACS profiles for EdU incorporation, propidium iodide staining (late apoptosis marker) and presence of cleaved caspase 3 (early apoptosis marker) and (b) the corresponding mean intensity values in the various experimental conditions. NT, not treated

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us